A former prime-time news anchor with over two decades of international journalism experience, Isabelle moderates at the highest level of global leadership. From heads of state to Fortune 500 CEOs, she is trusted to shape complex, high-stakes conversations with authority, precision and presence. Combining editorial depth with stage command, she transforms panels into meaningful, memorable dialogue.

Isabelle was the lead anchor for Euronews-NBC and criss-crossed the planet interviewing heads of state and government, CEOs and celebrities generating more than 3 million views on YouTube.

Isabelle has moderated at high-level and large-scale events throughout her career, including the first ever EU Presidential debate, deep dives at the Davos World Economic Forum and the European Commission. Now, this is her principal activity: she works with corporates, international organisations and NGOs around the world on issues relating to all things health, sustainability, tech/AI and more. Today her clients include the European Commission, the UN, WHO, The Consumer Goods Forum, Proctor & Gamble, LEAP and Saatchi & Saatchi. She has been MC for award ceremonies for the UN, EU and chaired closed-door discussions including with former German Chancellor Angela Merkel and European leaders.

Her interviews include presidents and prime ministers from Russia, Iran, Brazil, Argentina, Germany, Italy, Portugal as well as the heads of the UN and the European Commission.  She has spoken to the King of Jordan, the Prince and Princess of Monaco, interviewed Richard Branson, Andrea Bocelli, Mike Tyson and Karl Lagerfeld to name but a few.

Before heading to Euronews, Isabelle worked for CNN, APTN and Reuters.

Isabelle is bilingual in French and English and holds British and German nationality. She is a disability activist, the President of a charity supporting people with autism and does pro-bono work with the charity Lake Aid, which helps unaccompanied minors, asylum seekers and homeless families.

H.E. Dr. Delese Mimi Amoakoa Darko is the inaugural Director-General of the African Medicines Agency (AMA), where she leads the continent’s flagship effort to strengthen regulatory systems, expand access to quality-assured medical products, and advance Africa’s health sovereignty.

A distinguished pharmacist, regulator, and public health leader with over three decades of experience, Dr. Darko previously served as Chief Executive Officer of Ghana’s Food and Drugs Authority (2017–2025). During her tenure, she led a comprehensive institutional transformation that culminated in the attainment of WHO Maturity Level 3, ISO certifications, and a significant reduction—by over 75%—in the circulation of unregistered medical products. Her leadership has been widely recognized for advancing regulatory excellence, systems integrity, and public health protection.

At AMA, Dr. Darko is driving a bold continental agenda focused on regulatory harmonization, capacity strengthening, digital regulatory innovation, and the promotion of local pharmaceutical manufacturing as a strategic pillar of Africa’s health security.

She holds a PhD in Pharmacology, an MBA, and a Bachelor of Pharmacy degree, and is a recipient of Ghana’s highest civilian honour, the Order of the Volta, in recognition of her outstanding contributions to public service and national development.

Penny Heaton, M.D., is Global Head of the Office of the Chief Medical Officer at Jonson & Johnson. She leads efforts to address global health challenges that focus on Medical Safety; Epidemiology; Bioethics, Policy & Partnerships; and Life Cycle Management in alignment with the company’s Credo.

With more than 20 years of experience in infectious diseases and vaccine development, Penny previously served as Chief Executive Officer of the Bill
& Melinda Gates Medical Research Institute (Gates MRI), leading the development of investigational products for tuberculosis, malaria and other diseases. She also worked as Director of Vaccine Development at the Gates Foundation, addressing diseases like HIV, rotavirus and polio.

Penny began her career at The Centers for Disease Control and Prevention where she focused on diarrheal disease surveillance and outbreak investigations, igniting her interest in infectious diseases. She is a graduate of the University of Louisville School of Medicine, board-certified
in Pediatrics, and a fellow of the American Academy of Pediatrics.

Dr. Florika Fink Hooijer leads the DG HERA in the European Commission. DG HERA’s primary mission is to counter vulnerabilities and strategic dependencies within the EU in relation to threat analysis, development, production, procurement, stockpiling and distribution of medical countermeasures, irrespective of the cause of the health emergency.

Florika combines strong leadership skills with in-depth experience in EU policy making and international negotiations. A lawyer by training, she holds extensive expertise in foreign and security policy, humanitarian aid and disaster risk reduction, including civil-military cooperation as well as environmental policies.

Michael Lobritz, MD, PhD is Global Head of the Infectious Diseases at F. Hoffmann La-Roche, Ltd (Roche) in Basel, where the Roche team is pursuing the discovery and clinical development of novel antibiotics and antivirals. Founded in 1896 in Basel, Switzerland, Roche has grown into the world’s largest biotechnology company and global leader in in vitro diagnostics. He also serves on committees and boards focused on the challenges of antimicrobial resistance (AMR) and infectious diseases, including the AMR Industry Alliance and AMR Action Fund. Prior to joining Roche in 2017, Michael was attending physician in medicine and infectious diseases at Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School, both in Boston, USA. He is a Fellow of the Infectious Diseases Society of America.

Full bio available here